Admission to Trading of Transferable Securities
Summary by AI BETAClose X
SANTANDER UK PLC
(LEI: PTCQB104N23FMNK2RZ28)
STRUCTURED NOTE AND CERTIFICATE PROGRAMME
NOTIFICATION OF ADMISSION TO TRADING OF TRANSFERABLE SECURITIES
The following transferrable securities issued by Santander UK plc (the Issuer) have today 3 November 2026 been admitted to trading on the main market of the London Stock Exchange plc:
Issue of £4,884,351.00 Equity Index Linked Notes due 2031 (the Series 1330 Notes) (XS3429325171) (the Notes).
The Notes are issued under the Issuer’s Notes and Certificates programme pursuant to the base prospectuses dated 30 September 2025 and 29 September 2026, as supplemented from time to time (the Base Prospectus), read together with the Amended and restated Final Terms dated 20 August 2026 replacing the Final Terms relating to the N&C Securities dated 13 July 2026 (the Final Terms).
Full information on the Issuer and the offer of the Notes is only available on the basis of the Base Prospectus, read together with the Final Terms.
The Base Prospectus and the Final Terms have been published on the website of the Issuer at Santander UK Notes and Certificates Programme | About Santander
For further information, please contact:
The Structured Notes Desk: structurednotesafm@santander.co.uk
Please note that the information contained in the Base Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus and/or the Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and/or the Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus, and/or the Final Terms, you must ascertain from the Base Prospectus and/or the Final Terms whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
The Final Terms referenced herein does not constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act.
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 hours ago Johnson Matthey
- 10 hours ago Galliford Try
- 10 hours ago Galliford Try
- 10 hours ago Centrica
- 11 hours ago Smith & Nephew